Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $3.8850 (1.44%) ($3.8850 - $3.8850) on Fri. Jan. 14, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.67% (three month average) | RSI | 39 | Latest Price | $3.8850(1.44%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1.2% a day on average for past five trading days. | Weekly Trend | CGEN declines -3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(85%) ARKG(81%) ARKK(81%) IWO(80%) SKYY(80%) | Factors Impacting CGEN price | CGEN will decline at least -2.335% in a week (0% probabilities). VIXM(-71%) VXX(-53%) UUP(-21%) UNG(-14%) TLT(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.335% (StdDev 4.67%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-5.46(-240.54%) | Resistance Level | $4.26 | 5 Day Moving Average | $4.04(-3.84%) | 10 Day Moving Average | $4.16(-6.61%) | 20 Day Moving Average | $4.26(-8.8%) | To recent high | -45.8% | To recent low | 1.4% | Market Cap | $321m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |